4 steps to establishing a new approach to innovation


Innovation is often seen as the driving force behind progress in healthcare, yet meaningful advancements rarely stem from a single breakthrough. Instead, it’s the outcome of a deliberate, well-managed process.

I’ve discovered during my time as a leader in clinical diagnostics that relying on chance encounters and fragmented processes is no longer sufficient for driving diagnostic innovation in a rapidly evolving healthcare landscape.

Driving sustainable progress requires a deliberate, broad framework for innovation, built on engaging stakeholders, crafting a clear strategy, securing dedicated resources, and communicating intentionally.

This approach ensures that innovation is not just encouraged but enabled, supported, and strategic for your organization.

1.

Engage stakeholders early and often


The first step is to bring the right voices to the table from the very beginning. When setting out to revamp the approach to innovation, I recommend starting by gathering your leadership team for regular meetings. These discussions reveal that each area of the organization has its own approach, priorities, and challenges. Engaging stakeholders early ensures that your innovation strategy reflects the realities of your entire organization. This inclusivity fosters buy-in, surfaces practical insights, and sets the stage for a culture of collaboration.

2.

Create a strategy that combines creativity and structure


Innovation thrives when you pair creative thought with strategic intent. A well-crafted strategy provides clarity and direction. Further, using that strategy to determine where to invest in innovation ensures that efforts align with the needs of the patients and your organization’s goals and long-term vision. Most importantly, it transforms innovation from a series of chance encounters into a repeatable, scalable process.

It can be helpful to manage innovation across your organization as a single portfolio. In my experience, this has included consolidating the tracking, funding, and support for translational research, innovation, and test development. This approach ensures you elevate new ideas within a broader strategic plan while also eliminating confusion about how and where to access resources for innovation efforts.

3.

Identify and secure dedicated resources


An innovation strategy cannot succeed without the right resources. I’ve discovered this often requires treating innovation as a separate investment instead of something that happens alongside daily operations. When innovation and production share the same pool of resources, it often results in “starving innovation to feed production.”

By securing dedicated funding and support for innovation, you enable your teams to pursue high-impact projects without sacrificing operational excellence.

4.

Communicate and manage change with intention


Even positive change can be unsettling. That’s why clear, consistent communication is essential. As leaders, we must articulate not only what is changing, but why. Teams need to understand how new priorities are set, how their work fits into the bigger picture, and what success looks like. When I’ve led efforts to establish or refresh an innovation strategy, it has been a priority to communicate openly about our new approach, the rationale behind it, and the benefits. This transparency reduces uncertainty, builds trust, and helps staff adapt to new ways of working. It also fosters a sense of shared purpose, which is critical for sustaining momentum.

Propelling impactful innovation

Establishing a new approach to innovation is as much about people and processes as it is about ideas. With a framework that centralizes oversight, fosters collaboration, and aligns innovation with strategic goals, you can empower teams to pursue high-impact projects. The result is a resilient innovation engine that advances next-generation diagnostics and builds a culture of purposeful innovation, delivering measurable value for patients, staff, and the organization.

Learn more about innovation at Mayo Clinic Laboratories.

William Morice, II, M.D., Ph.D.

William Morice II, M.D., Ph.D., is the president and chief executive officer of Mayo Clinic Laboratories. Dr. Morice served as the chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic from 2015 to 2022. He is a consultant in the Division of Hematopathology and served as the chair of this division from 2009 to 2015. Dr. Morice currently serves as board chair of the American Clinical Laboratory Association.